Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (51)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by King, T. J.
Right arrow Articles by Bertram, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, T. J.
Right arrow Articles by Bertram, J. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 21, No. 6, 1097-1109, June 2000
© 2000 Oxford University Press


Cancer Biology

Reduced levels of connexin43 in cervical dysplasia: inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression

Timothy J. King1,2,5, Laurie H. Fukushima1, A. David Hieber3, Kelly A. Shimabukuro1, Wael A. Sakr4 and John S. Bertram1,6

1 Molecular Carcinogenesis, Cancer Research Center of Hawaii, University of Hawaii at Manoa, Honolulu, HI 96813,
2 Cell, Molecular and Neurosciences Program, Department of Cell and Molecular Biology, University of Hawaii at Manoa, Honolulu, HI 96822,
3 Department of Plant Molecular Physiology, University of Hawaii at Manoa, Honolulu, HI 96822 and
4 Pathology Department, Harper Hospital, Wayne State University, Detroit, MI 48201, USA

Loss of gap junctional intercellular communication (GJIC) has been linked to aberrant proliferation and an enhanced neoplastic phenotype. Many human tumors, including the cervical carcinoma line HeLa, have been reported to be deficient in expression of the gap junction protein connexin43 (Cx43) and GJIC. To determine if this is an early event in carcinogenesis, we utilized immunohistochemistry to screen a series of cervical biopsy samples and demonstrated a major reduction in Cx43 expression in dysplastic regions compared to normal epithelia. To determine whether this loss influences the neoplastic behavior of cervical carcinoma cells, we have constructed HeLa cell lines in which Cx43 expression can be induced in response to doxycycline. This approach allows for the discrimination of Cx43-mediated effects from those due to pre-existing clonal heterogeneity. Cx43 induction in these cells led to assembly of functional junctions but did not alter growth control in vitro as measured by logarithmic growth, saturation density or focus formation when in co-culture with growth-controlled fibroblasts. However, Cx43 induction decreased two indices of neoplasia: it reduced anchorage-independent growth and attenuated the growth rate of tumor xenografts. These results indicate that established HeLa cell lines are unresponsive to Cx43-mediated signals which are thought to mediate growth control of non-transformed cells, however, Cx43 expression can still reduce aspects of the neoplastic phenotype of these cells, indicating that loss of connexin signaling in dysplastic cells may contribute to their neoplastic progression.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
F. M. Muggia, G. J. Peters, and J. R. Landolph Jr.
XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on September 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center
Mol. Cancer Ther., May 1, 2009; 8(5): 992 - 999.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Peterson-Roth, C. M. Brdlik, and P. M. Glazer
Src-Induced Cisplatin Resistance Mediated by Cell-to-Cell Communication
Cancer Res., April 15, 2009; 69(8): 3619 - 3624.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. M. Hix, D. A. Frey, M. D. McLaws, M. Osterlie, S. F. Lockwood, and J. S. Bertram
Inhibition of chemically-induced neoplastic transformation by a novel tetrasodium diphosphate astaxanthin derivative
Carcinogenesis, September 1, 2005; 26(9): 1634 - 1641.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Tanmahasamut and N. Sidell
Up-Regulation of Gap Junctional Intercellular Communication and Connexin43 Expression by Retinoic Acid in Human Endometrial Stromal Cells
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4151 - 4156.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. G. Bravo and A. Alonso
Mucosal Human Papillomaviruses Encode Four Different E5 Proteins Whose Chemistry and Phylogeny Correlate with Malignant or Benign Growth
J. Virol., December 15, 2004; 78(24): 13613 - 13626.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Gellhaus, X. Dong, S. Propson, K. Maass, L. Klein-Hitpass, M. Kibschull, O. Traub, K. Willecke, B. Perbal, S. J. Lye, et al.
Connexin43 Interacts with NOV: A POSSIBLE MECHANISM FOR NEGATIVE REGULATION OF CELL GROWTH IN CHORIOCARCINOMA CELLS
J. Biol. Chem., August 27, 2004; 279(35): 36931 - 36942.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. J. King and P. D. Lampe
Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation
Carcinogenesis, May 1, 2004; 25(5): 669 - 680.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Huang, Y. Lin, C. C. Wang, J. Gano, B. Lin, Q. Shi, A. Boynton, J. Burke, and R.-P. Huang
Connexin 43 Suppresses Human Glioblastoma Cell Growth by Down-Regulation of Monocyte Chemotactic Protein 1, as Discovered Using Protein Array Technology
Cancer Res., May 1, 2002; 62(10): 2806 - 2812.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
O. Kucuk, F. H. Sarkar, W. Sakr, Z. Djuric, M. N. Pollak, F. Khachik, Y.-W. Li, M. Banerjee, D. Grignon, J. S. Bertram, et al.
Phase II Randomized Clinical Trial of Lycopene Supplementation before Radical Prostatectomy
Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 861 - 868.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.